M8 Pharmaceuticals, Inc
www.moksha8.commoksha8 is a specialty pharmaceutical company focused on the commercialization of innovative and established therapeutics in the two major Latin America markets, Brazil and Mexico. Our understanding of the regulatory complexities, our stringent quality assurance, our adherence to international standards and our integrated service offering make us the perfect partner for pharmaceutical companies looking to establish, maintain or expand their business presence in the major two Latin America Pharmaceuticals markets. Our vision is far-reaching. We aim at becoming the preferred pharmaceutical partner for high-value innovative and proven therapies across Latin America. Our commitment to making effective therapies accessible to Latin American population is at the center of our business.
Read moremoksha8 is a specialty pharmaceutical company focused on the commercialization of innovative and established therapeutics in the two major Latin America markets, Brazil and Mexico. Our understanding of the regulatory complexities, our stringent quality assurance, our adherence to international standards and our integrated service offering make us the perfect partner for pharmaceutical companies looking to establish, maintain or expand their business presence in the major two Latin America Pharmaceuticals markets. Our vision is far-reaching. We aim at becoming the preferred pharmaceutical partner for high-value innovative and proven therapies across Latin America. Our commitment to making effective therapies accessible to Latin American population is at the center of our business.
Read moreCountry
State
Pennsylvania
Industry
Founded
2007
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Executive Chairman China
Email ****** @****.comPhone (***) ****-****District Manager
Email ****** @****.comPhone (***) ****-****District Manager
Email ****** @****.comPhone (***) ****-****Key Account Coordinator
Email ****** @****.comPhone (***) ****-****
Technologies
(4)